Methods for reducing mortality associated with acute...

Details Methods for reducing mortality associated with acute... Methods for reducing mortality associated with acute...

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61K 31/00 (2006.01) A61K 38/00 (2006.01) A61P 9/10 (2006.01)

Patent

CA 2511659

Methods of reducing mortality in myocardial infarction patients receiving a stent in connection with percutaneous transluminal coronary angioplasty include administering an anti-inflammatory compound to the patient. In one embodiment, the anti-inflammatory compound is an antibody-to a complement component.

L'invention concerne des procédés de réduction de la mortalité des patients atteints d'un infarctus du myocarde et recevant un extenseur lors d'une angioplastie coronaire transluminale percutanée. Ces procédés comportent l'administration au patient d'un composé anti-inflammatoire. Selon un mode de réalisation, le composé anti-inflammatoire est un anticorps au composé complément.

Affiliated with

Also associated with

Rating

Methods for reducing mortality associated with acute... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for reducing mortality associated with acute..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for reducing mortality associated with acute... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2009084